Shanghai Yizhong Pharmaceutical Co Ltd (688091) — Capital Reinvestment Ratio
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Capital Reinvestment Ratio of 1.44x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥21.03 Million) in capital expenditures (CN¥30.36 Million). See Shanghai Yizhong Pharmaceutical Co Ltd (688091) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Yizhong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2022–2024)
This chart tracks Shanghai Yizhong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Yizhong Pharmaceutical Co Ltd from 2022 to 2024. For live market cap and broader valuation context, see Shanghai Yizhong Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.03x | CN¥39.44 Million | CN¥80.04 Million | ▲ +1900.3% |
| 2023 | 0.10x | CN¥86.55 Million | CN¥8.78 Million | ▼ -68.7% |
| 2022 | 0.32x | CN¥110.78 Million | CN¥35.88 Million | — |